FDA Inspection
Front Pharmaceutical PLCFront Pharmaceutical PLC – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Front Pharmaceutical PLC, with an inspection on March 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 44cfdda1-5dd3-4cab-9e74-206ec8715f46
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1264019
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Front Pharmaceutical PLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Front Pharmaceutical PLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.